KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Shares Outstanding (2016 - 2025)

Eli Lilly (LLY) has disclosed Shares Outstanding for 13 consecutive years, with $950.6 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Shares Outstanding fell 0.93% year-over-year to $950.6 million, compared with a TTM value of $950.6 million through Mar 2022, down 0.93%, and an annual FY2021 reading of $954.1 million, up 195817.04% over the prior year.
  • Shares Outstanding was $950.6 million for Q1 2022 at Eli Lilly, roughly flat from $954.1 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $1.1 billion in Q1 2018 and bottomed at $487000.0 in Q2 2020.
  • Average Shares Outstanding over 5 years is $577.7 million, with a median of $954.1 million recorded in 2021.
  • The sharpest move saw Shares Outstanding crashed 99.95% in 2020, then skyrocketed 196918.89% in 2021.
  • Year by year, Shares Outstanding stood at $604000.0 in 2018, then decreased by 12.25% to $530000.0 in 2019, then fell by 8.11% to $487000.0 in 2020, then soared by 195817.04% to $954.1 million in 2021, then dropped by 0.37% to $950.6 million in 2022.
  • Business Quant data shows Shares Outstanding for LLY at $950.6 million in Q1 2022, $954.1 million in Q4 2021, and $463000.0 in Q3 2021.